AI News Feed
Market watch
Research

Shaoshupai Article Explains Rosacea as a Common but Often Undiagnosed Cause of Facial Redness

A Shaoshupai article dated September 19, 2026, explains rosacea symptoms, how it differs from acne, seborrheic dermatitis and barrier damage, and what patients can do about triggers, skincare and treatment.

The author describes increasingly sensitive skin, redness and dryness, with cheeks turning red and hot when entering rooms with sharp temperature differences. The article says these symptoms may be rosacea. Its best-known sign, a rosacea nose, appears in a later and more severe subtype and is more common in men, but women are the largest affected group overall.

The main symptoms are redness and heat, which almost all patients experience. Temperature changes, sun exposure, emotional fluctuations or spicy food can trigger redness and heat within seconds or minutes, followed by slow fading. In healthy skin, blood vessels contract when the stimulus disappears, but in rosacea facial blood vessels have dysfunction and are difficult to contract after dilation. Episodic redness gradually becomes persistent redness in the central face, especially the nose, cheeks and chin.

Patients may feel facial heat because local blood flow increases and nerve endings are highly sensitive. Long-term inflammation damages the skin barrier, causing dryness and stinging or burning when ordinary skincare products, cleansers or even water touch the face, which is why rosacea is often mistaken for a damaged skin barrier. Rosacea can also cause red bumps and pustules with white fluid driven by local inflammation and immune reactions; unlike ordinary acne, they have no comedones, and squeezing them does not produce hard oil plugs. A small number of patients develop hyperplasia and hypertrophy, with chronic inflammation stimulating fibroblasts and sebaceous glands, leading to fibrosis and sebaceous gland hyperplasia, most often on the nose. Less common symptoms affect the eyes, including blepharitis, dryness, foreign body sensation and swelling as inflammation spreads to the ocular mucosa and meibomian glands.

The article distinguishes rosacea from ordinary acne, seborrheic dermatitis and barrier damage. Ordinary acne has comedones and is linked to androgen-driven sebum production, abnormal follicular keratinization and immune inflammation; it appears across the face and can extend to the chest and back, and usually does not come with episodic flushing and telangiectasia. Seborrheic dermatitis is a chronic inflammation associated with Malassezia and concentrates in sebum-rich areas such as nasal folds, eyebrows, hairline and scalp, producing dark red patches with oily yellow scales and itching, but usually not the burning and stinging of rosacea. Sensitive skin and barrier damage are often not primary diseases but result from over-cleansing, frequent acid use or extreme climate, causing stinging, tightness and temporary redness; they usually do not cause persistent erythema or new papules and pustules, and can improve after stopping irritants and repairing the stratum corneum. The article notes these conditions can coexist, so patients with mixed symptoms or poor treatment response should consult a doctor.

The article says the full mechanism of rosacea is not fully understood. Current consensus is that it is a complex disease arising from genetic background, local immune dysregulation, abnormal neurovascular responses and environmental factors. Treatment has shifted from simple antibacterial approaches to phenotype-based choices including barrier care, topical drugs, systemic drugs, eye treatment, photoelectric or medical aesthetic methods. Not everyone develops all symptoms, and many patients remain in the first or second stage, especially those who start standardized management early. Rhinophyma and other hyperplasia are possible outcomes when inflammation is left uncontrolled for a long time, which the article says is why early inflammation control matters.

To avoid triggers, the article says the underlying problem is vascular and neural hyperreactivity. A Japanese survey of more than 100 patients found sun exposure, emotional stress and extreme weather were the most common triggers; intense exercise, alcohol, spicy food and hot drinks also affected many people. For women, hormonal changes during the menstrual cycle, including perimenopausal hot flashes, may be triggers. Because individual differences are large, the article recommends recording possible factors for two to four weeks to identify the most influential ones. Daily sun protection is the most important measure, preferably through physical blocking such as umbrellas, sunglasses and hats. Patients should avoid sharp temperature changes, use lukewarm water for washing, avoid saunas, hot springs and direct hot air from air conditioners, and exercise in cool periods with cooling measures. If dryness worsens symptoms, increasing indoor humidity may help. The article advises reducing spicy food and hot drinks, avoiding alcohol because it worsens flushing, and managing stress through sleep and stress relief.

For skincare, the article recommends a minimalist, gentle routine because the stratum corneum barrier is generally damaged. Patients should cleanse with lukewarm water at least once a day using fingers, not scrubbing, and choose gentle fragrance-free amino acid cleansers rather than strong soap-based cleansers. If gentle cleansing is still uncomfortable, lotion cleansing can be used with a simple, fragrance-free, low-alcohol moisturizing lotion. Moisturizers should be simple and ceramide-containing, and alcohol-containing products should be avoided. Sunscreen should preferably be a pure physical sunscreen based on zinc oxide or titanium dioxide, combined with hard sun protection when possible. Patients should avoid toners, astringents, chemical exfoliants and beauty salon treatments that promote strong cleaning or exfoliation. During an acute flare, all complex steps should be paused, leaving only gentle cleansing, simple moisturizing and physical sun protection until a dermatologist can be consulted. The article warns against self-use or long-term use of topical corticosteroids.

When daily care cannot control inflammation, red rash and pustules, medication is needed, the article says. Current drug treatment focuses on anti-inflammation and regulating the skin microbiome, with vasoconstrictors considered according to patient needs. All drugs require a doctor's prescription or guidance. For rash and mild redness, topical ointments are often used. Azelaic acid can inhibit inflammatory factors and regulate keratin metabolism and can be first-line or maintenance therapy. Ivermectin has anti-mite and anti-inflammatory effects and is a main drug for papulopustular rosacea. Metronidazole is a classic topical gel often used for mild to moderate erythema and papules. The article adds that it is for general health and medical science reference only, not medical advice, and cannot replace individualized assessment by a qualified professional.

Editor's Summary

A Shaoshupai article says rosacea is a common, often undiagnosed cause of facial redness and heat, with symptoms that can be mistaken for acne, seborrheic dermatitis or barrier damage. It recommends trigger avoidance, sun protection, gentle skincare and doctor-guided medication, and stresses that early inflammation control can prevent progression to severe forms such as rhinophyma.